Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Total Liabilities (2020 - 2025)

Historic Total Liabilities for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to $494.3 million.

  • Bioventus' Total Liabilities fell 1515.83% to $494.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $494.3 million, marking a year-over-year decrease of 1515.83%. This contributed to the annual value of $542.4 million for FY2024, which is 804.35% down from last year.
  • According to the latest figures from Q3 2025, Bioventus' Total Liabilities is $494.3 million, which was down 1515.83% from $505.5 million recorded in Q2 2025.
  • Over the past 5 years, Bioventus' Total Liabilities peaked at $1.0 billion during Q4 2022, and registered a low of $422.8 million during Q2 2021.
  • In the last 5 years, Bioventus' Total Liabilities had a median value of $584.6 million in 2023 and averaged $603.8 million.
  • As far as peak fluctuations go, Bioventus' Total Liabilities skyrocketed by 14013.5% in 2022, and later plummeted by 4261.83% in 2023.
  • Bioventus' Total Liabilities (Quarter) stood at $618.2 million in 2021, then skyrocketed by 55.36% to $960.4 million in 2022, then plummeted by 38.59% to $589.8 million in 2023, then decreased by 8.04% to $542.4 million in 2024, then decreased by 8.85% to $494.3 million in 2025.
  • Its last three reported values are $494.3 million in Q3 2025, $505.5 million for Q2 2025, and $505.9 million during Q1 2025.